Naganawa Satoshi, Yokoyama Masaru, Shiino Teiichiro, Suzuki Takeyuki, Ishigatsubo Yoshiaki, Ueda Atsuhisa, Shirai Akira, Takeno Mitsuhiro, Hayakawa Satoshi, Sato Shigehiro, Tochikubo Osamu, Kiyoura Shingo, Sawada Kaori, Ikegami Takashi, Kanda Tadahito, Kitamura Katsuhiko, Sato Hironori
Department of Public Health, Yokohama City University School of Medicine, Kanagawa, Japan.
PLoS One. 2008 Sep 12;3(9):e3206. doi: 10.1371/journal.pone.0003206.
The third variable region (V3) of the human immunodeficiency virus type 1 (HIV-1) envelope gp120 subunit participates in determination of viral infection coreceptor tropism and host humoral immune responses. Positive charge of the V3 plays a key role in determining viral coreceptor tropism. Here, we examined by bioinformatics, experimental, and protein modelling approaches whether the net positive charge of V3 sequence regulates viral sensitivity to humoral immunity. We chose HIV-1 CRF01_AE strain as a model virus to address the question. Diversity analyses using CRF01_AE V3 sequences from 37 countries during 1984 and 2005 (n = 1361) revealed that reduction in the V3's net positive charge makes V3 less variable due to limited positive selection. Consistently, neutralization assay using CRF01_AE V3 recombinant viruses (n = 30) showed that the reduction in the V3's net positive charge rendered HIV-1 less sensitive to neutralization by the blood anti-V3 antibodies. The especially neutralization resistant V3 sequences were the particular subset of the CCR5-tropic V3 sequences with net positive charges of +2 to +4. Molecular dynamics simulation of the gp120 monomers showed that the V3's net positive charge regulates the V3 configuration. This and reported gp120 structural data predict a less-exposed V3 with a reduced net positive charge in the native gp120 trimer context. Taken together, these data suggest a key role of the V3's net positive charge in the immunological escape and coreceptor tropism evolution of HIV-1 CRF01_AE in vivo. The findings have molecular implications for the adaptive evolution and vaccine design of HIV-1.
人类免疫缺陷病毒1型(HIV-1)包膜糖蛋白120亚基的第三个可变区(V3)参与病毒感染共受体嗜性的决定以及宿主体液免疫反应。V3的正电荷在决定病毒共受体嗜性方面起关键作用。在此,我们通过生物信息学、实验和蛋白质建模方法研究V3序列的净正电荷是否调节病毒对体液免疫的敏感性。我们选择HIV-1 CRF01_AE毒株作为模型病毒来解决这个问题。对1984年至2005年期间来自37个国家的CRF01_AE V3序列(n = 1361)进行的多样性分析表明,由于正选择受限,V3净正电荷的减少使V3的变异性降低。一致地,使用CRF01_AE V3重组病毒(n = 30)进行的中和试验表明,V3净正电荷的减少使HIV-1对血液中抗V3抗体的中和作用敏感性降低。特别具有中和抗性的V3序列是CCR5嗜性V3序列的特定子集,其净正电荷为+2至+4。gp120单体的分子动力学模拟表明,V3的净正电荷调节V3的构象。这一点以及已报道的gp120结构数据预测,在天然gp120三聚体环境中,V3的净正电荷减少,其暴露程度降低。综上所述,这些数据表明V3的净正电荷在HIV-1 CRF01_AE体内的免疫逃逸和共受体嗜性进化中起关键作用。这些发现对HIV-1的适应性进化和疫苗设计具有分子层面的意义。